Mycobacteria have been implicated in the pathogenesis of autoimmunity. To determine the potential effect of mycobacterial antigens on peripheral blood mononuclear cells (PBMC), we analyzed PBMC incubated with the acetoneprecipitable fraction of Mycobacterium tuberculosis (AP-MT) for changes in cellular protein expression. Two-dimensional gel analysis showed induction of a 36-kD polypeptide identified as proliferating cell nuclear antigen (PCNA), a known autoantigen, after incubation with AP-MT. PCNA plays a role in cell proliferation and is expressed as a late growth regulated factor. However, its synthesis in response to AP-MT was induced as an early event. The early induction of PCNA was regulated at a posttranscriptional level and was restricted to T cells. Treatment of PBMC with known T cell mitogens, namely PHA, anti-CD3 antibodies, and staphylococcal superantigens failed to induce an early PCNA increase. The distinct characteristics of the AP-MT effect on PCNA expression suggest a separate mechanism of induction in response to AP-MT, compared with the late increase observed in response to mitogens. The induction of PCNA in response to mycobacterial antigens may represent a pathogenically relevant mechanism in autoimmunity. (J. 
Introduction
Proliferating cell nuclear antigen (PCNA)' is a cofactor of 1 . Abbreviations used in this paper: AP-MT, acetone-precipitable fraction of Mycobacterium tuberculosis; 2-D PAGE, two-dimensional PAGE; PCNA, proliferating cell nuclear antigen; PE, phycoerythrin; PVDF, polyvinyldifluoride; SEA, staphylococcal enterotoxin A; SEB, staphylococcal enterotoxin B.
ative activity and cell cycle progression in a variety of cell populations (8) (9) (10) (11) (12) . Interestingly, PCNA has also been implicated in autoimmunity. Approximately 3% of patients with systemic lupus erythematosus express anti-PCNA antibodies (13, 14) . The underlying mechanism(s) responsible for antibody formation against certain cellular proteins but not others is unknown.
Mycobacteria have been suggested as potential triggering agents in certain autoimmune conditions. Evidence to that effect includes the high prevalence of antinuclear antibodies, rheumatoid factor, and other autoantibodies in the sera of patients with pulmonary tuberculosis (for review see reference 15) , induction of autoimmune arthritis in rats immunized with complete Freund's adjuvant (16) , the high incidence of inflammatory arthritis in humans after BCG immunotherapy (17) , and the reactivity of synovial fluid and peripheral blood T lymphocytes from patients with rheumatoid arthritis (RA) to mycobacterial heat shock proteins ( 18) and to the acetone-precipitable fraction of Mycobacterium tuberculosis (AP-MT) (19, 20) .
Our previous studies of RA synovial fluid cells have shown that AP-MT selectively activates, and can be used to expand, a subset of y6 T cells (21) . Proliferation of these cells in response to AP-MT requires a close contact with antigen-presenting cells (22) . Presentation of AP-MT to y6 T cells seems to have distinct characteristics. Unlike presentation of nominal antigens and superantigens, presentation of AP-MT is independent of MHC molecules (22, 23) .
To better understand the relationship between mycobacteria and autoimmunity, we have investigated the molecular changes that peripheral blood mononuclear cells undergo after their exposure to AP-MT. Here we report that AP-MT, specifically, induced a posttranscriptional upregulation of the autoantigen PCNA in peripheral blood T lymphocytes. Unlike its induction in response to mitogen stimulation, which occurs as a late event during cell cycle progression, induction of PCNA by AP-MT occurred as an early event and was dissociated from cell cycle progression.
Methods
Antigens and antibodies. AP-MT was prepared from M. tuberculosis strain H37Ra (Difco Laboratories, Inc., Detroit, MI) as previously described (19 Cell culture. All experiments, unless stated otherwise, were performed in serum-free RPMI 1640 medium containing 1% Nutridoma HU (Boehringer Mannheim Biochemicals), 10 mM Hepes, 200 mM glutamine, and 1% penicillin/streptomycin (referred to below as Nutridoma medium). Peripheral blood mononuclear cells (PBMC) were isolated from healthy donors using a Ficoll density-gradient technique. PBMC at concentrations of 3-6 X 106/ml in Nutridoma medium were cultured at 370C in polypropylene tubes for 24 or 48 h. Antigens were added subsequently at different time points to allow stimulation with the tested antigen during the last 1, 2, 4, 24, or 48 h of incubation. This method was used to assure identical handling of all samples during the harvesting stage. Identical results were obtained when incubation with the antigens was allowed from the beginning of the culture period. Concentrations of the tested antigens were predetermined in dose-response experiments and included 20-100 tzg/ml AP-MT, 2-10 pg/ml PHA, 100 ng/ml SEA or SEB, or 1:100 dilution of OKT3 ascites. At the end of the incubation period, the cells were centrifuged at 6,000 rpm in an Eppendorf microfuge (Eppendorf North America, Inc., Madison, WI), and the supernatant was decanted. Cells were washed three times in Nutridoma medium.
Two-dimensional polyacrylamide gel electrophoresis (2-D PAGE). Cell pellets were lysed in 40 1l of a detergent lysate containing 8 M urea, 2% (vol/vol) Nonidet P-40 surfactant (Hoefer Scientific Instruments, San Francisco, CA), 20 mM ampholytes (pH 3.5-10) (Pharmacia LKB Biotechnology Inc., Piscataway, NJ), 2% (vol/vol) 2-mercaptoethanol, and 0.2 mM phenylmethylsulfonyl fluoride (Sigma Immunochemicals, St. Louis, MO) in distilled deionized water. 2-D PAGE was performed as described previously (24) . 25-pl aliquots containing -70 pig of protein were applied to isofocusing gels. First dimension gels contained 50 ml of ampholytes/liter (pH 3.5-10). Isofocusing was performed at 1,200 V for 16 h and 1,500 V for the last 2 h. For the second dimension separation, an acrylamide gradient of 11.4-14.0% was used. Protein spots were visualized by a silver-staining technique (25) . Quantification of spots on silver-stained gels was performed as described previously (26) . Each gel was scanned in a 1,024 x 1,024 pixel format, with 160 pim as the pixel width. All gel images were digitized and analyzed. The integrated intensities of PCNA and seven other reference proteins were measured in units of optical density times square millimeter. The reference spots were used to adjust for gel-togel variation in staining or amount of protein loaded (26) . Data were analyzed using the Michigan Interactive Data Analysis System statistical package (27) .
[ (28) . The relative position of the spots detected was compared with the position of the polypeptides identified by silver stain and immunoblot (29) . Individual spots were quantitated using ImageQuant software (Molecular Dynamics, Inc.). Results are expressed as Phosphorlmager signal per hours of exposure.
Immunoblots. Cell pellets were lysed, and proteins were resolved by 2-D PAGE. Samples were prepared as described (30) with some modifications: after protein transfer to Immobilon-P PVDF, membranes were placed in a blocking solution containing 5% nonfat milk and 0.02% sodium azide and 0.02% Tween 20 (Sigma Immunochemicals) in PBS (pH 7.4) for 4 h to equilibrate the membrane and to block unbound sites. The membranes were then transferred to a fresh blocking solution containing a mixture of anti-PCNA antibody 19F4 and antiactin antibody HHF35, both at a concentration of 5 pg/ml, and incubated overnight at 40C. The membranes were washed twice in PBS and once in blocking solution and incubated for 4 h with '25I-labeled sheep anti-mouse IgG (Dupont/New England Nuclear, Boston, MA) diluted 1:1,000 in PBS. Membranes were then exposed to storage phosphor imaging plates for 48 h and analyzed as described above.
Northern blot analyses. Northern blot analysis was performed as described previously (31 ) . PBMC were stimulated with AP-MT in Nutridoma medium. Cell aliquots were harvested, and total cellular RNA was prepared by the RNAzol' B method (Cinna Scientific, Inc., Friendswood, TX) as described (32) . Total cellular RNA was also prepared from Jurkat cells as a positive control. The purified RNA was dissolved in diethyl pyrocarbonate-treated 0.5% SDS and quantitated by spectrophotometry as well as a quantitative agarose gel. Equal amounts of RNA were denatured in formaldehyde and formamide, followed by fractionation on a 1% agarose formaldehyde gel and transferred to Magna Graph NT membranes (Westboro, MA). The filters were hybridized to an [a-32P]dCTP nick translated 1.2-kb HindIll/ BamHI human PCNA cDNA probe (donated by Dr. Eng Tan, Scripps Clinics, La Jolla, CA) as described (33) . After overnight hybridization, the membranes were washed in high stringency conditions, air-dried, and visualized by Phosphorlmager (28) . The membranes were stripped and rehybridized with a 1.4-kb PstI-digested human HLA B7 cDNA probe (donated by Dr. David Fox, University of Michigan, Ann Arbor, MI) as an internal control to assure equal RNA loading.
Flow cytometry and cell cycle analysis. PBMC were stimulated with AP-MT or PHA as described above. The cells were washed twice in PBS containing 1% FCS (Gibco Laboratories, Grand Island, NY) and incubated for 30 min with normal mouse serum (Sigma Immunochemicals), diluted 1:5, to block nonspecific binding sites. The cells were washed again twice in 1% FCS/PBS and subsequently incubated for 30 min with either anti-CD3 monoclonal antibody conjugated to PE (Leu-4 PE; Becton Dickinson Immunocytometry Systems) or a PEconjugated mouse IgG1 (MsIgG, RD1; Coulter Corp.) as an isotypematched control. To obtain intranuclear staining, cells were permeabilized by Triton X (34) as follows: each sample was washed twice in 1% FCS/PBS and then fixed with 1% paraformaldehyde for 20 min on ice and permeabilized with 1 ml 0.1% Triton X-100 (Sigma Immunochemicals) as described (34) . After (Fig. 1, A and B (26) . The location of the 36-kD polypeptide in relation to other landmarks in 2-D gels was characteristic of PCNA (27) .
To confirm the identity of the 36-kD protein, we performed Western blot analysis. 2-D gels were transferred to Immobilon-P PVDF membranes and stained with a mixture of two monoclonal antibodies, an anti-PCNA antibody and an antiactin antibody, for reference. Fig. 2 Fig. 3 A. Only the CD3 + population showed an early increase in PCNA staining after AP-MT stimulation (Fig. 3 A) . The increment in the percentage of cells expressing PCNA over time in each subset is plotted in Fig. 3 B. While a significant increase in the percentage of T cells showing positive staining with anti-PCNA antibody could be detected 1 h after stimulation with AP-MT, no comparable increase in staining in the CD3 -cell population was seen. The mean percent increase of PCNApositive CD3 + cells at 4 h in eight consecutive experiments was 11.1+3.5, compared with 1.1±0.3 in the CD3-population (P < 0.001). In addition, two-color flow cytometry experiments using antimonocyte and anti-B cell antibodies showed no increase in PCNA positivity at the early time points in those subsets (data not shown). Thus, we conclude that the early PCNA increase observed in PBMC is contributed primarily by T cells.
To determine the antigenic specificity of the early increase in PCNA protein, PBMC were stimulated with several known T cell mitogens. As shown in Fig. 4 , neither PHA, OKT3, SEA, nor SEB resulted in an early increase in PCNA. As expected, however, the PHA, OKT3, and SEA did induce a late increase in PCNA at 24-48 h (Fig. 4) .
The mechanism for the early increase in PCNA. Previous studies have shown that expression of PCNA in proliferating cells is regulated by both transcriptional and posttranscriptional mechanisms (33) (34) (35) (36) . As shown in Fig. 5 , an increase in PCNA, based on uptake of radiolabeled methionine, could be detected within 1 h after incubation of PBMC with AP-MT, indicating de novo synthesis of PCNA. To determine whether the increase in PCNA at the protein level was paralleled by an increase in PCNA mRNA, we performed Northern blot analysis. There was no detectable increase in PCNA mRNA expression at the early time points (Fig. 6) . Furthermore, actinomycin D had no effect on early PCNA synthesis (Fig. 7) . There was no significant decrease in radiolabeled methionine incorporation into PCNA at the early time points in the presence of actinomycin D. There was, however, complete inhibition at 24 h. Taken together, these results suggest that the early induction of PCNA protein in response to AP-MT occurs as a posttranscriptional event, whereas the late increase is regulated primarily at the level of transcription.
The early increase in PCNA is independent of cell cycle progression. Previous studies of cells induced to proliferate have shown that PCNA protein expression is induced during the GI /S transition and peaks in the S phase of the cell cycle ( 1, 9, 11) . To determine whether the early induction of PCNA observed in response to AP-MT correlates with G1 /S transition, cell cycle analysis after AP-MT stimulation was undertaken. As can be seen in Fig. 8 , the AP-MT-induced early increase in PCNA expression was not accompanied by cell cycle progression from GI to S phase. Treatment with hydroxyurea to induce cell cycle arrest did not prevent the early increase in PCNA in response to AP-MT (data not shown).
Discussion
Our data show that stimulation with a mycobacterial extract results in early induction of PCNA protein in T lymphocytes. This rapid induction occurs in response to AP-MT, but not in response to mitogens that induce PCNA late during progression through the cell cycle. The early increase in PCNA occurs by a posttranscriptional mechanism.
The significance of these findings is fourfold. First, this is the first report implicating a microbial antigen in the induction of a known autoantigen, PCNA. Second, the mechanism of induction is distinct from that of known mitogens. Third, induction of PCNA by AP-MT is not accompanied by cell cycle progression. Fourth, our findings may provide important clues about the relationship between mycobacteria and autoimmunity.
Our flow cytometry data indicate that the early increase of PCNA in PBMC occurs in T cells. Previous studies have shown that PCNA can be induced by T cell mitogens as a late event during cell cycle progression. A 20% increase in PCNA protein has been demonstrated by immunofluorescence in peripheral blood lymphocytes stimulated for 72 h with PHA, pokeweed mitogen, or concanavalin A (13) . Similarly, a PHA-induced PCNA mRNA synthesis was detected after 48 h of stimulation (37) . T Induction of PCNA has been described in several other systems. Human breast epithelial cultures stimulated with a variety of growth factors, including epidermal growth factor, transforming growth factor-a, or a combination of insulin/hydrocortisone/cholera toxin, showed increased PCNA protein only after 48 h (39) . Similar studies with quiescent mouse 3T3 cells showed no increase in the protein after the addition of serum, platelet-derived growth factor, or fibroblast growth factor until 8-12 h after stimulation (40) . Studies using an 1L-2-dependent T cell line demonstrated an increase in PCNA mRNA within 4-8 h of 11L-2 stimulation, but synthesis did not become maximal until 24-28 h after stimulation (41) . It is unlikely that IL-2 is the mediator for the induction of PCNA in response to AP-MT, as peripheral blood T lymphocytes, unlike cloned T cell lines, express very low levels of 11L-2 receptors. In addition, PBMC cultured with AP-MT do not produce any detectable IL-2. Recombinant human IL-2, even in superphysiologic concentrations, The kinetics of PCNA induction in response to AP-MT relative to other inducers of PCNA suggests that a different signaling pathway may be responsible for induction in response to AP-MT compared with induction in response to known mitogens. Alternatively, it is possible that AP-MT activates the same The association of PCNA expression with cell cycle progression in proliferating cells has been studied previously (10, 12, 13, 29, 44) . PCNA levels increase in late Gl and peak during S phase and diminish in G2/M (1, 11, 9, 45) . This increase has been shown to be most noticeable in cells that have been previously resting, although spontaneously proliferating cells have been shown to exhibit a two-to threefold increase in PCNA during the S phase (46) . The expression of PCNA has also been shown to be linked to DNA synthesis. Changes in the nuclear distribution of PCNA to sites of DNA synthesis appear to be dependent on DNA replication (47) . It has been shown, however, that although DNA synthesis requires PCNA expression (3-5, 7, 48) , PCNA can be expressed in the presence of DNA synthesis inhibitors (33, 42, 49) . It is therefore conceivable that an increase in PCNA could occur independent of DNA synthesis and that the regulation of this protein could be dissociated from the regulation of other DNA synthesisrelated factors. Our data are consistent with this possibility.
Another significant finding is that the early increase in PCNA was regulated by a posttranscriptional mechanism. Some previous studies of proliferating cells have shown that PCNA expression is regulated at the level of transcription (33, 35) . Others have demonstrated a role for both transcriptional and posttranscriptional mechanisms. Increased PCNA mRNA stability after antigen stimulation has been found in 3T3 cells transfected with the human PCNA cDNA (36) and in a cloned murine T helper cell line (34) . Our results with actinomycin D (Fig. 7) indicate that inhibition of transcription has no effect on the early synthesis of PCNA protein, although a complete inhibition was found at 24 h. Thus, the early and late induction of PCNA differ not only in their kinetics but also in their regula- Time (hrs) Figure 8 . AP-MT-induced PCNA increase is independent of GI /S switch. PBMC were stimulated for various times with AP-MT. (15) (16) (17) (18) (19) (20) (21) and PCNA is a known autoantigen (13, 14) , it is tempting to speculate that the early increase of PCNA levels in peripheral blood T lymphocytes induced by AP-MT may represent a pathogenically relevant cellular event in autoimmunity.
